In recent years, vaccination coverage rates against Human Papilloma Virus (HPV) in Europe
have shown a decreasing trend and remain below the required standard. The present study …

The human papillomavirus (HPV) is the most common diagnosed sexually transmitted
infection in the world. The most frequent disease linked to HPV is cervical cancer as well as …

Background Persistent infection with certain subtypes of human papillomavirus (HPV) is a
necessary cause of cervical cancer. Although two prophylactic vaccines have been licensed …

Human papilloma virus (HPV) is the most common sexually transmitted infection in the USA
with some strains increasing the risk of certain cancers. The HPV vaccine, introduced in …

Despite the existence of a safe and effective vaccine, human papillomavirus (HPV) remains
prevalent in the United States, with late adolescence and early adulthood being periods of …

This cross-sectional survey determined the vaccine hesitancy related to Human
papillomavirus (HPV) and the determinants among parents of adolescents aged 12 and 13 …

Background The human papillomavirus (HPV) vaccine reduces the burden of cervical and
other cancers. In numerous countries, a slow uptakeof this vaccine persists, calling for a …

Objectives Contrary to the optimistic forecasts, existing until 2008 and despite the
incorporation of the vaccine into the Greek National Immunization Program, six years later …

Objectives The aim of this research was twofold:(1) develop an instrument to assess
knowledge regarding human papillomavirus (HPV) and its vaccine and utilize this …

Human papillomavirus (HPV) remains the most common sexually transmitted infection (STI)
in the US despite widespread availability of a safe, effective vaccine. Although young adults …